{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:42:03Z","timestamp":1780321323250,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,31]]},"DOI":"10.7759\/cureus.61409","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T09:48:26Z","timestamp":1717148906000},"source":"Crossref","is-referenced-by-count":6,"title":["A Comprehensive Review of the Role of Biomarkers in the Early Detection of Endocrine Disorders in Critical Illnesses"],"prefix":"10.7759","author":[{"given":"Pallavi","family":"Deulkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Singam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2014.19.4.184","article-title":"Endocrine disorders and the neurologic manifestations","volume":"19","author":"Yu J","year":"2014","unstructured":"Yu J. Endocrine disorders and the neurologic manifestations. Ann Pediatr Endocrinol Metab. 2014, 19:184-90. 10.6065\/apem.2014.19.4.184","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8529(03)00005-7","article-title":"Endocrine evaluation of patients with critical illness","volume":"32","author":"Van den Berghe G","year":"2003","unstructured":"Van den Berghe G. Endocrine evaluation of patients with critical illness. Endocrinol Metab Clin North Am. 2003, 32:385-410. 10.1016\/s0889-8529(03)00005-7","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061630","article-title":"Biomarkers as biomedical bioindicators: approaches and techniques for the detection, analysis, and validation of novel biomarkers of diseases","volume":"15","author":"Ahmad A","year":"2023","unstructured":"Ahmad A, Imran M, Ahsan H. Biomarkers as biomedical bioindicators: approaches and techniques for the detection, analysis, and validation of novel biomarkers of diseases. Pharmaceutics. 2023, 15:1630. 10.3390\/pharmaceutics15061630","journal-title":"Pharmaceutics"},{"key":"ref4","article-title":"Endocrine disorders in the critically ill","author":"Hall GM","year":"2010","unstructured":"Hall GM, Hunter JM, Cooper MS. Endocrine disorders in the critically ill. Core Topics in Endocrinology in Anaesthesia and Critical Care. Cambridge University Press, Cambridge, United Kingdom; 2010. 125:84."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0897190019834771","article-title":"Management of endocrine emergencies in the ICU","volume":"32","author":"Jacobi J","year":"2019","unstructured":"Jacobi J. Management of endocrine emergencies in the ICU. J Pharm Pract. 2019, 32:314-26. 10.1177\/0897190019834771","journal-title":"J Pharm Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/bjaed\/mkx023","article-title":"Endocrine problems in the critically ill 2: endocrine emergencies","volume":"17","author":"Kerr DE","year":"2017","unstructured":"Kerr DE, Wenham T, Newell-Price J. Endocrine problems in the critically ill 2: endocrine emergencies. BJA Educ. 2017, 17:377-82. 10.1093\/bjaed\/mkx023","journal-title":"BJA Educ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/CNQ.0000000000000411","article-title":"Endocrine emergencies in the medical intensive care unit","volume":"45","author":"Nasrullah A","year":"2022","unstructured":"Nasrullah A, Azharuddin S, Young M, Kejas A, Dumont T. Endocrine emergencies in the medical intensive care unit. Crit Care Nurs Q. 2022, 45:266-84. 10.1097\/CNQ.0000000000000411","journal-title":"Crit Care Nurs Q"},{"key":"ref8","unstructured":"Endocrine-disrupting chemicals (EDCs). (2022). Accessed. May 10, 2024: https:\/\/www.endocrine.org\/patient-engagement\/endocrine-library\/edcs."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.04.002","article-title":"Overview of the endocrine response to critical illness: how to measure it and when to treat","volume":"25","author":"Hassan-Smith Z","year":"2011","unstructured":"Hassan-Smith Z, Cooper MS. Overview of the endocrine response to critical illness: how to measure it and when to treat. Best Pract Res Clin Endocrinol Metab. 2011, 25:705-17. 10.1016\/j.beem.2011.04.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref10","unstructured":"Pesticide-induced diseases. endocrine disruption. (2024). Accessed: May 10, 2024: https:\/\/www.beyondpesticides.org\/resources\/pesticide-induced-diseases-database\/endocrine-disruption."},{"key":"ref11","article-title":"Challenges and strategies in timely and accurate patient diagnosis","volume":"7","author":"Andrew Y","year":"2023","unstructured":"Andrew Y. Challenges and strategies in timely and accurate patient diagnosis. Biol Med Case Rep. 2023, 7:169.","journal-title":"Biol Med Case Rep"},{"key":"ref12","unstructured":"Early diagnosis 101. how timely diagnosis can make all the difference. (2023). Accessed: May 10, 2024: https:\/\/www.linkedin.com\/pulse\/early-diagnosis-101-how-timely-can-make-all-alejandro-ledesma\/."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12091","article-title":"Challenges faced in the cancer diagnosis and management-COVID-19 pandemic and beyond-lessons for future","volume":"8","author":"Aden D","year":"2022","unstructured":"Aden D, Zaheer S, Raj S. Challenges faced in the cancer diagnosis and management-COVID-19 pandemic and beyond-lessons for future. Heliyon. 2022, 8:e12091. 10.1016\/j.heliyon.2022.e12091","journal-title":"Heliyon"},{"key":"ref14","unstructured":"What is a biomarker? A simple explanation of their definitions, types, and applications. (2024). Accessed. May 10, 2024: https:\/\/bitesizebio.com\/26559\/biomarkers-explained\/."},{"key":"ref15","unstructured":"7 types of biomarkers. (2024). Accessed. May 10, 2024: https:\/\/www.atlasantibodies.com\/knowledge-hub\/blog\/7-types-of-biomarkers\/."},{"key":"ref16","unstructured":"Significance of biomarkers in endocrinology. (2024). Accessed. May 10, 2024: https:\/\/www.icliniq.com\/articles\/endocrine-diseases\/biomarkers-in-endocrinology."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00963","article-title":"Current standards and recent advances in biomarkers of major endocrine tumors","volume":"9","author":"Luo Y","year":"2018","unstructured":"Luo Y, Zhu H, Tan T, He J. Current standards and recent advances in biomarkers of major endocrine tumors. Front Pharmacol. 2018, 9:963. 10.3389\/fphar.2018.00963","journal-title":"Front Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10030063","article-title":"Advantages and pitfalls in fluid biomarkers for diagnosis of Alzheimer\u2019s disease","volume":"10","author":"Omar SH","year":"2020","unstructured":"Omar SH, Preddy J. Advantages and pitfalls in fluid biomarkers for diagnosis of Alzheimer\u2019s disease. J Pers Med. 2020, 10:63. 10.3390\/jpm10030063","journal-title":"J Pers Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2174\/1389201018666170601091205","article-title":"Advantages and limitations of current biomarker research: from experimental research to clinical application","volume":"18","author":"Kim SH","year":"2017","unstructured":"Kim SH, Wei\u00df C, Hoffmann U, Borggrefe M, Akin I, Behnes M. Advantages and limitations of current biomarker research: from experimental research to clinical application. Curr Pharm Biotechnol. 2017, 18:445-55. 10.2174\/1389201018666170601091205","journal-title":"Curr Pharm Biotechnol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1878-5085-4-7","article-title":"Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine","volume":"4","author":"Drucker E","year":"2013","unstructured":"Drucker E, Krapfenbauer K. Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J. 2013, 4:7. 10.1186\/1878-5085-4-7","journal-title":"EPMA J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0757-5","article-title":"Liquid biomarkers in melanoma: detection and discovery","volume":"17","author":"Lim SY","year":"2018","unstructured":"Lim SY, Lee JH, Diefenbach RJ, Kefford RF, Rizos H. Liquid biomarkers in melanoma: detection and discovery. Mol Cancer. 2018, 17:8. 10.1186\/s12943-018-0757-5","journal-title":"Mol Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-21-0364","article-title":"Biomarkers indicating tissue thyroid hormone status: ready to be implemented yet?","volume":"253","author":"Jansen HI","year":"2022","unstructured":"Jansen HI, Bruinstroop E, Heijboer AC, Boelen A. Biomarkers indicating tissue thyroid hormone status: ready to be implemented yet?. J Endocrinol. 2022, 253:R21-45. 10.1530\/JOE-21-0364","journal-title":"J Endocrinol"},{"key":"ref23","article-title":"Autoantibodies as biomarkers in thyroid diseases","volume":"12","author":"Nakano M","year":"2023","unstructured":"Nakano M, Miyazaki A, Konishi H, Yukimatsu R, Watanabe T, Koshiba M. Autoantibodies as biomarkers in thyroid diseases. J Thyroid Disord Ther. 2023, 12:1-5.","journal-title":"J Thyroid Disord Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-873","article-title":"Biomarkers of thyroid function and autoimmunity for predicting high-risk groups of thyroid cancer: a nested case-control study","volume":"14","author":"Cho YA","year":"2014","unstructured":"Cho YA, Kong SY, Shin A, Lee J, Lee EK, Lee YJ, Kim J. Biomarkers of thyroid function and autoimmunity for predicting high-risk groups of thyroid cancer: a nested case-control study. BMC Cancer. 2014, 14:873. 10.1186\/1471-2407-14-873","journal-title":"BMC Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14363","article-title":"Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors","volume":"111","author":"Kurimoto C","year":"2020","unstructured":"Kurimoto C, Inaba H, Ariyasu H, et al.. Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors. Cancer Sci. 2020, 111:1468-77. 10.1111\/cas.14363","journal-title":"Cancer Sci"},{"key":"ref26","unstructured":"Adrenal insufficiency (Addison\u2019s disease). (2020). Accessed. May 10, 2024: https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/underactive-adrenal-glands--addisons-disease."},{"key":"ref27","unstructured":"Adrenal insufficiency. (2022). Accessed. May 10, 2024: https:\/\/www.endocrine.org\/patient-engagement\/endocrine-library\/adrenal-insufficiency."},{"key":"ref28","unstructured":"Adrenal insufficiency & Addison\u2019s disease. (2024). Accessed. May 10, 2024: https:\/\/www.niddk.nih.gov\/health-information\/endocrine-diseases\/adrenal-insufficiency-addisons-disease."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46484","article-title":"Advancements in the management of endocrine system disorders and arrhythmias: a comprehensive narrative review","volume":"15","author":"Kumari Y","year":"2023","unstructured":"Kumari Y, Bai P, Waqar F, et al.. Advancements in the management of endocrine system disorders and arrhythmias: a comprehensive narrative review. Cureus. 2023, 15:e46484. 10.7759\/cureus.46484","journal-title":"Cureus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.107.064089","article-title":"Androgen actions and the ovary","volume":"78","author":"Walters KA","year":"2008","unstructured":"Walters KA, Allan CM, Handelsman DJ. Androgen actions and the ovary. Biol Reprod. 2008, 78:380-9. 10.1095\/biolreprod.107.064089","journal-title":"Biol Reprod"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2014.05.007","article-title":"Rationale and design of the GUIDE-IT study: guiding evidence based therapy using biomarker intensified treatment in heart failure","volume":"2","author":"Felker GM","year":"2014","unstructured":"Felker GM, Ahmad T, Anstrom KJ, et al.. Rationale and design of the GUIDE-IT study: guiding evidence based therapy using biomarker intensified treatment in heart failure. JACC Heart Fail. 2014, 2:457-65. 10.1016\/j.jchf.2014.05.007","journal-title":"JACC Heart Fail"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-070240","article-title":"Biomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2 trial): study protocol for an international, prospective, randomised controlled multicentre trial","volume":"13","author":"von Groote T","year":"2023","unstructured":"von Groote T, Meersch M, Romagnoli S, et al.. Biomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2 trial): study protocol for an international, prospective, randomised controlled multicentre trial. BMJ Open. 2023, 13:e070240. 10.1136\/bmjopen-2022-070240","journal-title":"BMJ Open"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.308079","article-title":"Biomarker-guided drug therapy: personalized medicine for treating Alzheimer's disease","volume":"16","author":"Syal C","year":"2021","unstructured":"Syal C, Wang J. Biomarker-guided drug therapy: personalized medicine for treating Alzheimer's disease. Neural Regen Res. 2021, 16:2010-1. 10.4103\/1673-5374.308079","journal-title":"Neural Regen Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.04.04","article-title":"Biomarker-guided antibiotic therapy-strengths and limitations","volume":"5","author":"Nora D","year":"2017","unstructured":"Nora D, Salluh J, Martin-Loeches I, P\u00f3voa P. Biomarker-guided antibiotic therapy-strengths and limitations. Ann Transl Med. 2017, 5:208. 10.21037\/atm.2017.04.04","journal-title":"Ann Transl Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2021.100410","article-title":"Circulating biomarkers for monitoring therapy response and detection of disease progression in lung cancer patients","volume":"28","author":"de Kock R","year":"2021","unstructured":"de Kock R, Borne BV, Soud MY, et al.. Circulating biomarkers for monitoring therapy response and detection of disease progression in lung cancer patients. Cancer Treat Res Commun. 2021, 28:100410. 10.1016\/j.ctarc.2021.100410","journal-title":"Cancer Treat Res Commun"},{"key":"ref36","article-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","author":"FDA-NIH Biomarker Working Group","year":"2016","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource. Food and Drug Administration, Silver Spring, MD; 2016."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.10.006","article-title":"On predictions in critical care: the individual prognostication fallacy in elderly patients","volume":"61","author":"Beil M","year":"2021","unstructured":"Beil M, Sviri S, Flaatten H, et al.. On predictions in critical care: the individual prognostication fallacy in elderly patients. J Crit Care. 2021, 61:34-8. 10.1016\/j.jcrc.2020.10.006","journal-title":"J Crit Care"},{"key":"ref38","article-title":"Prediction of outcome from critical illness. A comparison of clinical judgment with a prediction rule","volume":"149","author":"Brannen AL 2nd","year":"1989","unstructured":"Brannen AL 2nd, Godfrey LJ, Goetter WE. Prediction of outcome from critical illness. A comparison of clinical judgment with a prediction rule. Arch Intern Med. 1989, 149:1083-6.","journal-title":"Arch Intern Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1597-6","article-title":"Predicting critical illness mortality and personalizing therapy: moving to multi-dimensional data","volume":"21","author":"Puthucheary ZA","year":"2017","unstructured":"Puthucheary ZA, Wischmeyer P. Predicting critical illness mortality and personalizing therapy: moving to multi-dimensional data. Crit Care. 2017, 21:20. 10.1186\/s13054-016-1597-6","journal-title":"Crit Care"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-022-06739-5","article-title":"Towards predicting the quality of survival after critical illness","volume":"48","author":"Nguyen TL","year":"2022","unstructured":"Nguyen TL, Hodgson CL, van den Boogaard M. Towards predicting the quality of survival after critical illness. Intensive Care Med. 2022, 48:726-7. 10.1007\/s00134-022-06739-5","journal-title":"Intensive Care Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1262046","article-title":"Editorial: novel biomarkers and extracellular vesicles in endocrine hypertension and related disorders","volume":"14","author":"Carvajal CA","year":"2023","unstructured":"Carvajal CA, Young MJ, Romero DG. Editorial: novel biomarkers and extracellular vesicles in endocrine hypertension and related disorders. Front Endocrinol (Lausanne). 2023, 14:1262046. 10.3389\/fendo.2023.1262046","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0901","article-title":"Serum diiodotyrosine - a biomarker to differentiate destructive thyroiditis from Graves' disease","volume":"186","author":"Fujita N","year":"2022","unstructured":"Fujita N, Ono Y, Sano A, et al.. Serum diiodotyrosine - a biomarker to differentiate destructive thyroiditis from Graves' disease. Eur J Endocrinol. 2022, 186:245-53. 10.1530\/EJE-21-0901","journal-title":"Eur J Endocrinol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0177","article-title":"Applying precision medicine to the diagnosis and management of endocrine disorders","volume":"11","author":"Bidlingmaier M","year":"2022","unstructured":"Bidlingmaier M, Gleeson H, Latronico AC, Savage MO. Applying precision medicine to the diagnosis and management of endocrine disorders. Endocr Connect. 2022, 11:e220177. 10.1530\/EC-22-0177","journal-title":"Endocr Connect"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1021\/acs.iecr.2c04097","article-title":"Recent advances and emerging trends in cancer biomarker detection technologies","volume":"62","author":"Kumar RR","year":"2023","unstructured":"Kumar RR, Kumar A, Chuang C-H, Shaikh MO. Recent advances and emerging trends in cancer biomarker detection technologies. Ind Eng Chem Res. 2023, 62:5691-713. 10.1021\/acs.iecr.2c04097","journal-title":"Ind Eng Chem Res"},{"key":"ref45","unstructured":"The future of protein biomarker detection methods in neuropathology. (2023). Accessed. May 10, 2024: https:\/\/www.quanterix.com\/the-future-of-protein-biomarker-detection-methods-in-neuropathology\/."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100629","article-title":"Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias","volume":"22","author":"Teunissen CE","year":"2023","unstructured":"Teunissen CE, Kimble L, Bayoumy S, et al.. Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias. Mol Cell Proteomics. 2023, 22:100629. 10.1016\/j.mcpro.2023.100629","journal-title":"Mol Cell Proteomics"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020375","article-title":"Predictive biomarkers for immune-related endocrinopathies following immune checkpoint inhibitors treatment","volume":"15","author":"Shalit A","year":"2023","unstructured":"Shalit A, Sarantis P, Koustas E, Trifylli EM, Matthaios D, Karamouzis MV. Predictive biomarkers for immune-related endocrinopathies following immune checkpoint inhibitors treatment. Cancers (Basel). 2023, 15:375. 10.3390\/cancers15020375","journal-title":"Cancers (Basel)"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13323","article-title":"Biomarkers: promising and valuable tools towards diagnosis, prognosis and treatment of COVID-19 and other diseases","volume":"9","author":"Bodaghi A","year":"2023","unstructured":"Bodaghi A, Fattahi N, Ramazani A. Biomarkers: promising and valuable tools towards diagnosis, prognosis and treatment of COVID-19 and other diseases. Heliyon. 2023, 9:e13323. 10.1016\/j.heliyon.2023.e13323","journal-title":"Heliyon"},{"key":"ref49","unstructured":"Digital biomarkers. areas of application, use cases, and market overview. (2023). Accessed: May 10, 2024: https:\/\/binariks.com\/blog\/digital-biomarkers-in-healthcare\/."},{"key":"ref50","unstructured":"Patient stratification. leveraging biomarkers for precision medicine. (2023). Accessed: May 10, 2024: https:\/\/oxfordglobal.com\/biomarkers\/resources\/patient-stratification-leveraging-biomarkers-for-precision-medicine."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/257043-a-comprehensive-review-of-the-role-of-biomarkers-in-the-early-detection-of-endocrine-disorders-in-critical-illnesses","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T09:48:37Z","timestamp":1717148917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/257043-a-comprehensive-review-of-the-role-of-biomarkers-in-the-early-detection-of-endocrine-disorders-in-critical-illnesses"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.61409","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}